Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy

Brittney Schultz; Cuong V Nguyen; Erick Jacobson-Dunlop

doi:10.1016/j.jdcr.2018.05.021

Acquired epidermodysplasia verruciformis in setting of tumor necrosis factor-α inhibitor therapy

JAAD Case Rep. 2018 Sep 14;4(8):805-807. doi: 10.1016/j.jdcr.2018.05.021. eCollection 2018 Sep.

Authors

Brittney Schultz^{1

2}, Cuong V Nguyen^{1

2}, Erick Jacobson-Dunlop¹

Affiliations

¹ Department of Dermatology, University of Minnesota, Minneapolis, Minnesota.
² Department of Internal Medicine, University of Minnesota, Minneapolis, Minnesota.

No abstract available

Keywords: AEV, acquired epidermodysplasia verruciformis; EV, epidermodysplasia verruciformis; HPV, human papillomavirus; TNF, tumor necrosis factor; acquired epidermodysplasia verruciformis; human papillomavirus; immunosuppression; tumor necrosis factor-α inhibitor therapy.

Publication types

Case Reports